PATENT CLAIM ANALYSIS

Application Number: 16125252
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "313000"]

Abstract:
Analgesic compositions comprise an aminoquinoline together with an opioid, a non-steroidal anti-inflammatory drug (NSAID), a NE/5-HT reuptake inhibitor, or a combination thereof. The aminoquinoline potentiates bioactivity of opioids, NSAIDs and NE/5-HT reuptake inhibitors.

Claim (Index 1):
A pharmaceutical composition comprising an aminoquinoline compound of Formula in free acid form, free base form, or as a pharmacologically acceptable addition salt wherein:\n R 7  is alkyl (preferably a 3 to 6 carbon alky), or phenyl; \n R 8  is alkyl (preferably a 3 to 6 carbon alkyl), or phenyl; \n E 1  is \u2014C(\u2550O)R 9 ; \n each R 9  is H or C 1 -C 4  alkyl; \n each X 2  and X 3  independently is an electron withdrawing group (preferably halogen or nitro); \n together with an analgesic agent different from the aminoquinoline compound and selected from the group consisting of a NSAID, an opioid, a NE/5-HT reuptake inhibitor, and mixtures thereof.

Metadata:
- Claim Count in Document: 128.0
- Percentile: 97.0
- Lexical Diversity: 1.32258
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15318964', '12083110', '09171697', '13102705', '15279576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7310799520547321
- 35 USC 102 Novelty (BERT): 0.5986697360524662
- Combined Prediction Score: 0.7178389304545055
- Mean Citation Score: 349.545086
- Max Citation Score: 563.5349
- Similarity Product: 419.72729382834433

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test